Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment
Masato Nakaguro(Nagoya University Hospital), Toshitaka Nagao(Tokyo Medical University), Yuichiro Tada(Mita Hospital), Lori J. Wirth(Massachusetts General Hospital), Peter M. Sadow(Massachusetts Eye and Ear Infirmary), William C. Faquin(Massachusetts General Hospital)
Cited by 139
Related Papers
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653